25d
ProSomnus Sleep Technologies, Inc.: ProSomnus Receives FDA Class II Clearance for RPMO2 OSA Device
ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine, today ...
Near-infrared spectroscopy (NIRS) is an increasingly accepted noninvasive method for monitoring regional cerebral oxygen saturation (rScO 2) and cerebral fractional tissue oxygen extraction (cFTOE) in ...
SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE)-- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...
1 Department of Epidemiology & Biostatistics, Erasmus Medical Centre, the Netherlands 2 Department of Neurology, Erasmus Medical Centre, the Netherlands 3 Department of Radiology, University Hospital ...
Methods: To achieve these objectives, we included 14 healthy participants aged 23-39 years in the study, and we induced several stable plateaus of arterial oxygen saturation (SaO2) ranging from ...
Changes in arterial oxygen saturation (SaO2), procedural success rate, reperfusion rate, and complications were evaluated. Results: The procedural success rate was 100%, with an immediate complete ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results